AIM AIM ImmunoTech Inc
Company Analysis
Latest News
🔴 AIM ImmunoTech is trading 5% down today in a speculative, technically driven move
AIM ImmunoTech is trading at $0.27, down -5.01% in a speculative, technically driven move. - The decline reverses part of its 7.83% gain from August 5, 2026,...
🟢 AIM ImmunoTech is trading 8.9% up today on continued biotech momentum and speculative interest
AIM ImmunoTech is trading at $0.30 (8.9%) up in after-hours trading, extending a multi-day rebound fueled by broader biotech sector strength and speculative...
🟢 AIM ImmunoTech is trading 11% up today on sector momentum and speculative trading
AIM ImmunoTech is trading 11% up today at $0.29 as the stock extends a sharp multi-day rebound driven by broader biotech sector strength and speculative...
🟢 AIM ImmunoTech is trading 5.7% up today amid sector momentum and speculative trading
AIM ImmunoTech is trading 5.7% up today at $0.28 amid broader sector momentum and a lack of company-specific news. • The stock is extending a volatile...
🟢 AIM ImmunoTech is trading 10.7% up today on a light-liquidity rebound after recent weakness
AIM ImmunoTech is trading 10.7% up at $0.26 on what appears to be a light-liquidity rebound following recent weakness. • The move occurs in the absence of...
🟢 AIM ImmunoTech is trading 5.9% up today on a light-liquidity bounce despite no news
AIM ImmunoTech is trading 5.9% up at $0.25 on a light-liquidity bounce despite no fresh news or fundamental catalysts. • The move follows several choppy,...
🟢 AIM ImmunoTech is trading 6.4% up today in a light-liquidity pre-market move with no clear catalyst
AIM ImmunoTech is trading at $0.25 (6.4% up) in pre-market, bouncing modestly after several sessions of low-priced, choppy trading with no clear fundamental...
🔴 AIM ImmunoTech is trading 6.8% down today on broader biotech sector pressure
AIM ImmunoTech is trading at $0.23 (-6.76%) following a weak start to the session, likely driven by broader risk-off pressure in the biotech and small-cap...
🔴 AIM ImmunoTech is trading 5.6% down today after shareholder approval of a reverse split and dilutive share issuance
AIM ImmunoTech is trading at $0.24 (5.6% down) as investors continue to react to shareholder approval of a reverse stock split and significant dilutive share...
🔴 AIM ImmunoTech is trading 5% down today after shareholder approval of reverse split and dilutive share issuances
AIM ImmunoTech is trading 5% down at $0.26 following shareholder approval of a potential reverse stock split and significant new share issuances tied to...
AIM ImmunoTech Shareholders Approve Reverse Stock Split and Share Issuances
AIM ImmunoTech announced that stockholders approved all proposals at its Special Meeting on July 15, 2026. Key approvals include granting the Board of...
AIM ImmunoTech approves reverse split and share issuance, targeting NYSE compliance
AIM ImmunoTech (NYSE: AIM) shareholders approved all board proposals at a Special Meeting on July 15, 2026. The board is now authorized to enact a reverse...
🟢 AIM ImmunoTech is trading 5.47% up today despite no clear catalyst
AIM ImmunoTech is trading at $0.27 (+5.47%) today, with the upward move appearing to be an idiosyncratic gain as no new company-specific catalysts have been...
🔴 AIM ImmunoTech is trading 10.1% down
AIM ImmunoTech is trading at $0.25, down 10.1% from a comparison close of $0.28 during regular trading. This is a price-action follow-up, so a separate...
🔴 AIM ImmunoTech is trading 6.4% down today on dilution risks and upcoming special meeting
AIM ImmunoTech is trading at $0.27 (6.4% down) today, extending its weekly decline as the market weighs the impact of recent financing activities and dilution...
🔴 AIM extends move to 7.4% down
AIM is trading at $0.28, down 7.4% versus the comparison close of $0.31 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 AIM is trading 5.8% down today on dilution from recent financing and rights offerings
AIM is trading at $0.29 (5.8% down) following a series of recent dilutive financings that have increased share supply and pressured the stock. • The company...
🟢 AIM ImmunoTech Inc is trading 8.36% up in pre-market
AIM is trading at $0.30, up 8.36% in pre-market.
🔴 AIM is trading 6.8% down today amidst ongoing negative sentiment from recent dilutive financing
AIM is trading 6.8% down at $0.28, driven by continued investor reaction to recent dilutive financing activities. • This includes at-the-market offerings and...
🔴 AIM is trading 6.6% down today after financing dilution and prior listing-compliance pressure
AIM is trading at $0.29 (-6.57%) as financing dilution and listing compliance risks continue to weigh on the stock. • Recent pressure is tied to the company’s...